Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessnegative regulation of translational initiation in response to stress

EIF2AK4 PML

4.03e-055422GO:0032057
GeneOntologyBiologicalProcessmicrovillus organization

GLDN RAPGEF6 MINK1

4.50e-0534423GO:0032528
GeneOntologyBiologicalProcessnegative regulation of translation in response to stress

EIF2AK4 PML

6.04e-056422GO:0032055
DomainNa/H_exchanger_6

SLC9A7 SLC9A6

1.41e-053412IPR002090
DomainNaH_exchanger

SLC9A7 SLC9A6

1.68e-049412IPR004709
DomainCation/H_exchanger_CPA1

SLC9A7 SLC9A6

2.55e-0411412IPR018422
DomainNa_H_Exchanger

SLC9A7 SLC9A6

4.21e-0414412PF00999
DomainCation/H_exchanger

SLC9A7 SLC9A6

4.21e-0414412IPR006153
Domain-

JARID2 ARID1B

4.85e-04154121.10.150.60
DomainARID

JARID2 ARID1B

4.85e-0415412PF01388
DomainBRIGHT

JARID2 ARID1B

4.85e-0415412SM00501
DomainARID_dom

JARID2 ARID1B

4.85e-0415412IPR001606
DomainARID

JARID2 ARID1B

4.85e-0415412PS51011
DomainVWA

ITIH6 ITGAX

6.72e-0356412PF00092
Pubmed

A membrane-proximal region in the C-terminal tail of NHE7 is required for its distribution in the trans-Golgi network, distinct from NHE6 localization at endosomes.

SLC9A7 SLC9A6

1.42e-06242220364249
Pubmed

Molecular cloning and characterization of a novel (Na+,K+)/H+ exchanger localized to the trans-Golgi network.

SLC9A7 SLC9A6

1.42e-06242211279194
Pubmed

Discordant regulation of eIF2 kinase GCN2 and mTORC1 during nutrient stress.

EIF2AK4 MTOR

1.42e-06242234023907
Pubmed

Insulin inhibition of apolipoprotein B mRNA translation is mediated via the PI-3 kinase/mTOR signaling cascade but does not involve internal ribosomal entry site (IRES) initiation.

APOB MTOR

1.42e-06242217698027
Pubmed

SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.

MTOR PML

1.42e-06242225293974
Pubmed

PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.

MTOR PML

1.42e-06242223440206
Pubmed

Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR.

EIF2AK4 MTOR

1.42e-06242223216249
Pubmed

Effects of essential amino acids or glutamine deprivation on intestinal permeability and protein synthesis in HCT-8 cells: involvement of GCN2 and mTOR pathways.

EIF2AK4 MTOR

1.42e-06242221113813
Pubmed

The effect of anti‑HLA class I antibodies on the immunological properties of human glomerular endothelial cells and their modification by mTOR inhibition or GCN2 kinase activation.

EIF2AK4 MTOR

1.42e-06242233760196
Pubmed

PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4.

MTOR PML

4.27e-06342228332630
Pubmed

Infectious tolerance via the consumption of essential amino acids and mTOR signaling.

EIF2AK4 MTOR

4.27e-06342219567830
Pubmed

Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma.

EIF2AK4 MTOR

4.27e-06342225759478
Pubmed

Differential engagement of ORAI1 and TRPC1 in the induction of vimentin expression by different stimuli.

VIM TRPC1

4.27e-06342231243341
Pubmed

Electric field-induced suppression of PTEN drives epithelial-to-mesenchymal transition via mTORC1 activation.

VIM MTOR

4.27e-06342227919618
Pubmed

Pml represses tumour progression through inhibition of mTOR.

MTOR PML

4.27e-06342221387562
Pubmed

Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation.

EIF2AK4 MTOR

4.27e-06342222509023
Pubmed

Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol.

APOB MYLIP

8.53e-06442226786161
Pubmed

Origins and functional basis of regulatory CD11c+CD8+ T cells.

EIF2AK4 ITGAX

8.53e-06442219499519
Pubmed

GFAPδ expression in glia of the developmental and adolescent mouse brain.

VIM MCM2

8.53e-06442223285135
Pubmed

Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions.

SLC9A7 SLC9A6

8.53e-06442221171650
Pubmed

PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.

MTOR PML

8.53e-06442216915281
Pubmed

Canonical transient receptor channel 5 (TRPC5) and TRPC1/4 contribute to seizure and excitotoxicity by distinct cellular mechanisms.

EDIL3 TRPC1

8.53e-06442223188715
Pubmed

Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation.

SLC9A7 SLC9A6

1.42e-05542215522866
Pubmed

PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development.

MTOR PML

1.42e-05542227545895
Pubmed

Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.

MTOR TRPC1

1.42e-05542222446186
Pubmed

Loss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR and TFEB Signaling.

EDIL3 MTOR

1.42e-05542227875531
Pubmed

DNER acts as a neuron-specific Notch ligand during Bergmann glial development.

VIM DTX1

2.98e-05742215965470
Pubmed

Functions of a jumonji-cyclin D1 pathway in the coordination of cell cycle exit and migration during neurogenesis in the mouse hindbrain.

VIM JARID2

5.10e-05942217189626
Pubmed

Immunohistochemical Expression Pattern of FGFR1, FGFR2, RIP5, and HIP2 in Developing and Postnatal Kidneys of Dab1-/- (yotari) Mice.

VIM MTOR

6.37e-051042235216141
Pubmed

Mapping of multiple mouse loci related to the farnesyl pyrophosphate synthetase gene.

APOB IL9

6.37e-05104228499655
Pubmed

Mammalian target of rapamycin signaling is a key regulator of the transit-amplifying progenitor pool in the adult and aging forebrain.

VIM MTOR

7.78e-051142223100423
Pubmed

Olfactory receptor gene cluster on human chromosome 17: possible duplication of an ancestral receptor repertoire.

OR3A2 OR3A3

7.78e-05114228004088
Pubmed

Non-apical mitoses contribute to cell delamination during mouse gastrulation.

VIM EDIL3

7.78e-051142239198421
Pubmed

Genome-wide association study of sex hormones, gonadotropins and sex hormone-binding protein in Chinese men.

GLDN GYS1

9.32e-051242224049095
Pubmed

Discovery and refinement of loci associated with lipid levels.

VIM APOB SLC22A1 MYLIP

1.23e-0421142424097068
Pubmed

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.

ARID1B EDIL3

1.28e-041442223419831
Pubmed

Rap2A links intestinal cell polarity to brush border formation.

RAPGEF6 MINK1

1.48e-041542222797597
Pubmed

Identification of candidate genes at the corticoseptal boundary during development.

VIM JARID2

1.48e-041542216458080
Pubmed

Association of sixty-one non-synonymous polymorphisms in forty-one hypertension candidate genes with blood pressure variation and hypertension.

APOB GYS1

1.69e-041642217137217
Pubmed

Chfr is linked to tumour metastasis through the downregulation of HDAC1.

VIM MCM2

1.69e-041642219182791
Pubmed

Sequence, structure, and evolution of a complete human olfactory receptor gene cluster.

OR3A2 OR3A3

1.69e-041642210673334
Pubmed

In vivo visualization and molecular targeting of the cardiac conduction system.

VIM SLC22A1

1.91e-041742235951416
Pubmed

Macropinocytosis and TAK1 mediate anti-inflammatory to pro-inflammatory macrophage differentiation by HIV-1 Nef.

SLC9A7 SLC9A6

2.15e-041842224874739
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

VIM PABPC1L LTV1 PDE4B RAPGEF6 MTOR GYS1

2.24e-04103842726673895
Pubmed

OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.

VIM MTOR

2.95e-042142230662561
Pubmed

UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.

VIM MCM2 APOB LTV1 EDIL3

3.04e-0449142536273042
Pubmed

Mesenchymal expression of Foxl1, a winged helix transcriptional factor, regulates generation and maintenance of gut-associated lymphoid organs.

ITGAX IL9

3.54e-042342212648490
Pubmed

Sin3a is essential for the genome integrity and viability of pluripotent cells.

MCM2 EDIL3

3.54e-042342222206758
Pubmed

Genetic variation in healthy oldest-old.

APOB MTOR

3.86e-042442219680556
Pubmed

A chemical tool for blue light-inducible proximity photo-crosslinking in live cells.

VIM MTOR

4.20e-042542235211260
Pubmed

Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.

APOB PDE4B

4.54e-042642219060910
Pubmed

Unconventional myosin VI in the heart: Involvement in cardiac dysfunction progressing with age.

VIM MTOR

4.90e-042742237169038
Pubmed

Distribution of olfactory receptor genes in the human genome.

OR3A2 OR3A3

5.28e-04284229500546
Pubmed

Mice deficient in UXT exhibit retinitis pigmentosa-like features via aberrant autophagy activation.

VIM MTOR

5.28e-042842232744119
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

FSIP2 VIM RAPGEF6 MTOR MINK1 PML

5.55e-0486142636931259
Pubmed

Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.

APOB MYLIP

6.06e-043042219936222
Pubmed

UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.

VIM MTOR

6.06e-043042232867711
Pubmed

mTOR acts as a pivotal signaling hub for neural crest cells during craniofacial development.

VIM MTOR

7.34e-043342229975682
Pubmed

Biological, clinical and population relevance of 95 loci for blood lipids.

APOB SLC22A1 MYLIP

7.38e-0414642320686565
Pubmed

Synaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex.

VIM MTOR

8.26e-043542235858542
Pubmed

Choroid plexuses carry nodal-like cilia that undergo axoneme regression from early adult stage.

HYDIN DEUP1

8.26e-043542237890489
Pubmed

The genetic architecture of economic and political preferences.

DLGAP1 PDE4B

9.23e-043742222566634
Pubmed

Expressed genes in interleukin-4 treated B cells identified by cDNA representational difference analysis.

MCM2 PML

9.23e-04374229798653
Pubmed

An investigation into the human serum "interactome".

OR3A2 JARID2 PDE4B

9.97e-0416242315174051
Pubmed

TWIST1 interacts with β/δ-catenins during neural tube development and regulates fate transition in cranial neural crest cells.

VIM MTOR

1.03e-033942235781329
Pubmed

Chromosomal location of the octamer transcription factors, Otf-1, Otf-2, and Otf-3, defines multiple Otf-3-related sequences dispersed in the mouse genome.

VIM RNASE1

1.03e-03394221676977
Pubmed

Exome sequencing supports a de novo mutational paradigm for schizophrenia.

MTOR PML

1.08e-034042221822266
Cytoband5q31.1

RAPGEF6 IL9

1.54e-03634225q31.1
Cytoband17p13.3

OR3A2 OR3A3

2.98e-038842217p13.3
CytobandEnsembl 112 genes in cytogenetic band chr17p13

OR3A2 OR3A3 MINK1

3.92e-03346423chr17p13
GeneFamilyOlfactory receptors, family 3

OR3A2 OR3A3

3.46e-056282150
GeneFamilyAT-rich interaction domain containing

JARID2 ARID1B

2.40e-0415282418
GeneFamilySolute carriers

SLC9A7 SLC9A6 SLC22A1

2.26e-02395283752
CoexpressionGSE37532_WT_VS_PPARG_KO_LN_TREG_UP

SLC9A7 JARID2 ARID1B ATXN7L1 MINK1 PML

3.11e-07176416M8952
CoexpressionGSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP

VIM ELL2 ITGAX MINK1 MYLIP

9.10e-06181415M6323
ToppCellControl-Myeloid-Macrophage|Control / Disease state, Lineage and Cell class

VIM JARID2 RNASE1 PDE4B ELL2 ITGAX

2.91e-08196426e2c2a30fa3ee3034fbde5335be169e880dde622d
ToppCelldroplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 VIM EDIL3 ITGAX DTX1

6.01e-071734257456a417c5c1d4ba25f9489065aae322421308a6
ToppCelldroplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 VIM EDIL3 ITGAX DTX1

6.01e-0717342535586a9e5f15b41609b6224e33eb3aa3cb7e03b7
ToppCelldroplet-Large_Intestine-COLON:P+D-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 VIM EDIL3 ITGAX DTX1

6.01e-07173425cd635751f999e12b14c0accfa1c4c1fd3c1d4540
ToppCellControl-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations)

DOCK2 SLC9A7 JARID2 PDE4B ITGAX

7.94e-071834258f9c8e2436f18ea7c265b08e4e149e19cb513a16
ToppCellControl-APC-like|Control / group, cell type (main and fine annotations)

DOCK2 SLC9A7 JARID2 PDE4B ITGAX

7.94e-07183425c313ac72cc9fa1583456d452393f61f0a4ca33a8
ToppCellCOPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class

JARID2 DLGAP1 PDE4B ELL2 ITGAX

8.15e-07184425ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCellControl-Myeloid-Macrophage|World / Disease state, Lineage and Cell class

JARID2 RNASE1 PDE4B ELL2 ITGAX

1.06e-06194425c35bf04d5e7450cb6679a036fcabb1b28f409f29
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

VIM RNASE1 ELL2 ITGAX MYLIP

1.08e-06195425042b4f44f90eb23caadeced43699b51e5195ab04
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor

DOCK2 VIM GLDN ELL2 ITGAX

1.08e-0619542555e25f702af19146a161861cfd15f40bbda1dc35
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

VIM JARID2 PDE4B ELL2 ITGAX

1.11e-06196425555c9e443fe3b9893cb320b78d84002e1f8c1701
ToppCellCOVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations)

DOCK2 JARID2 PDE4B ELL2 ITGAX

1.11e-061964254929cfed1f150c1fde4d79cb49895c2ea467a18f
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

VIM JARID2 PDE4B ELL2 ITGAX

1.11e-06196425a1b21f4667c05e837a1229cc5934db805ad562c5
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

VIM JARID2 PDE4B ELL2 ITGAX

1.14e-0619742559aa4a31674125ae422450aee45db3ced5c405d3
ToppCellChildren_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor

DOCK2 VIM PDE4B GLDN ITGAX

1.14e-06197425f18807124b91310fcd84238484a80ecdba684679
ToppCellIPF-Myeloid-Macrophage|IPF / Disease state, Lineage and Cell class

VIM JARID2 RNASE1 ELL2 ITGAX

1.14e-06197425a2ffb33c7cad6be43cbb8ed9a91338923cc07db4
ToppCellnucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

DOCK2 RNASE1 PDE4B ELL2 ITGAX

1.14e-061974256f41c8f815851968849428ec92c16745bd01a3fb
ToppCellnucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

DOCK2 RNASE1 PDE4B ELL2 ITGAX

1.14e-06197425304044ace926943b8eb588f686ecbe5d1689a809
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)-D231|Adult / Lineage, Cell type, age group and donor

DOCK2 VIM PDE4B ELL2 ITGAX

1.17e-0619842579a415e19cedde13a88f5043d71557363f102322
ToppCellnucseq-Immune-Immune_Myeloid-iMON-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

VIM JARID2 PDE4B ELL2 ITGAX

1.17e-06198425e6dad9dea8cbd368b1b127572212cc913b909ffe
ToppCellnucseq-Immune-Immune_Myeloid-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

VIM JARID2 PDE4B ELL2 ITGAX

1.17e-06198425bf5806424be33790f78f1c160398046a8725e469
ToppCellCOPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class

JARID2 RNASE1 PDE4B ELL2 ITGAX

1.20e-061994251cf1b2d6debf9e3389f1829dcaa2857e9533a080
ToppCellCOPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class

JARID2 RNASE1 PDE4B ELL2 ITGAX

1.20e-061994254b9c53fb4f44190d2f6ad4d52b13be01ebe4955e
ToppCellcontrol-Myeloid-Monocyte-derived_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DOCK2 VIM PDE4B ITGAX

2.01e-05171424e828b684744a4fdf6b63ec033c4f000b39ca0d51
ToppCellNS-control-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DOCK2 VIM PDE4B ITGAX

2.16e-05174424758984730cd1c3ccf6866a3a8f03d6e002f3edb6
ToppCellControl-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations)

DOCK2 JARID2 PDE4B ITGAX

2.46e-0518042425ad95c3c30e3b82abe93bd77ba003f5c2241f7c
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JARID2 PDE4B ELL2 ITGAX

2.68e-05184424b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 PDE4B GLDN ITGAX

2.92e-051884240d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6
ToppCellMS-mono3|MS / Condition, Cell_class and T cell subcluster

GLDN ELL2 HTR2B ITGAX

2.92e-05188424a50a766c2f02e776c8e5c6e0833ec241c61831c4
ToppCellMS-mono3-|MS / Condition, Cell_class and T cell subcluster

GLDN ELL2 HTR2B ITGAX

2.92e-05188424e8c1c2941ca4919e0097a65b692b7af8018e8886
ToppCellCOPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class

JARID2 PDE4B ELL2 ITGAX

2.98e-05189424d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCellCOPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class

JARID2 PDE4B ELL2 ITGAX

2.98e-051894246294691231c7d38707323cf31578a107d3b2c622
ToppCellCOVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK2 JARID2 RNASE1 PDE4B

2.98e-051894242586f4088721c5debec86c2b211b739fd33713eb
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 PDE4B GLDN ITGAX

3.04e-051904247c402aa47f1bd7decacc366c1ed1a37e39b95c73
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PDE4B GLDN ELL2 ITGAX

3.04e-051904244d401b73c0e7eb38e95d0851a128bf12bb0d3a9f
ToppCellIPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class

JARID2 PDE4B ELL2 ITGAX

3.04e-05190424a099f51f2b7618b6712af38eedd5ee64d8663a4a
ToppCellControl-Myeloid|Control / group, cell type (main and fine annotations)

DOCK2 PDE4B GLDN ITGAX

3.10e-051914249c4acc5f3c2f9c0c5520863bb22f391774372347
ToppCellCOVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type

DOCK2 PDE4B GLDN ITGAX

3.10e-05191424dab953682b8c9ed680a799161f837f792a7e4f33
ToppCellCOVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK2 PDE4B GLDN ITGAX

3.17e-05192424bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DOCK2 APOB RNASE1 ITGAX

3.17e-05192424935a4a36881a9fa4daa02cba96af07f6686ed8d6
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor

DOCK2 VIM GLDN ITGAX

3.23e-05193424cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958
ToppCellRA-08._Macrophage|World / Chamber and Cluster_Paper

DOCK2 JARID2 PDE4B ITGAX

3.23e-051934245fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCellAT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

RNASE1 EDIL3 MUCL3 MYLIP

3.23e-051934248187f976fd2d11fad3286690f1a046e894772220
ToppCellControl-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class

JARID2 RNASE1 ELL2 ITGAX

3.23e-051934242a6d531abd34df20941cf3dac4fdfb1621a1bde6
ToppCellCOVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type

DOCK2 RNASE1 PDE4B ITGAX

3.30e-05194424f09675cd472200363c458952f00d2e41990800ee
ToppCellCOPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class

JARID2 PDE4B ELL2 ITGAX

3.30e-051944247d682408e9a6239a4e47befc9376e760cc3d133a
ToppCellRA-08._Macrophage|RA / Chamber and Cluster_Paper

DOCK2 JARID2 PDE4B ITGAX

3.30e-05194424ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCellIPF-Myeloid-Macrophage|World / Disease state, Lineage and Cell class

VIM JARID2 RNASE1 ITGAX

3.37e-0519542450edda117b438b9c3616191884007466f6d974f0
ToppCellCOVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations)

DOCK2 PDE4B ELL2 ITGAX

3.37e-05195424c172c5599379c29123340621a36bfb1fc90c2115
ToppCellChildren_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

DOCK2 GLDN ELL2 ITGAX

3.37e-051954249d649ac7d2af313481069c95349efc0c68449e2b
ToppCellmetastatic_Brain-Myeloid_cells-Microglia/Mac|metastatic_Brain / Location, Cell class and cell subclass

VIM RNASE1 GLDN ITGAX

3.37e-05195424ae48d493ebda5f87781181a3d1d73d8f84fc5e77
ToppCelldistal-Hematologic-OLR1+_Classical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

JARID2 PDE4B ELL2 ITGAX

3.43e-0519642480fc5b9e04ead0b38304dccbe39f66575e2bf203
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JARID2 PDE4B ELL2 ITGAX

3.43e-0519642401cea0bb0b938d0986fd2ddae06597b8af1768ee
ToppCelldistal-Hematologic-OLR1+_Classical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

JARID2 PDE4B ELL2 ITGAX

3.43e-051964243f57216dbc9ef28fca09bbb8805f7c15b03b99e8
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JARID2 PDE4B ELL2 ITGAX

3.43e-05196424c2bbb48c4aa979b03cb6f4ce9f351f492977c992
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JARID2 PDE4B ELL2 ITGAX

3.43e-0519642464c2abc0087bf2ae547932377f3662e3be1cc63e
ToppCellCOVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK2 JARID2 PDE4B ITGAX

3.50e-05197424e42910a653a1b5bd90c090e9665a84871ed2873f
ToppCellCOVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK2 JARID2 PDE4B ITGAX

3.50e-051974243912301018d0863144dcfac8d1fa8adc081748d7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 JARID2 PDE4B ITGAX

3.50e-05197424c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a
ToppCellCOVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type

DOCK2 JARID2 PDE4B ITGAX

3.50e-051974243896729740d151f0eb845f1961c7b969bfbdd28d
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PDE4B GLDN ITGAX

3.57e-05198424e125eb8aa57c172e5518874da1bd25998292f5e2
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PDE4B GLDN ITGAX

3.57e-051984240baeb8e2c199ff10bb5c829c523546af3c9227c1
ToppCell356C-Myeloid-Monocyte-CD14+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells)

VIM PDE4B ELL2 ITGAX

3.57e-051984248f53df66712c0b4a176098c0dbb3c2c13d3f56df
ToppCellPSB-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DOCK2 VIM PDE4B ITGAX

3.57e-05198424437e2f84b64d99928aedbab7366ff0ec91e74038
ToppCellAdult-Immune|Adult / Lineage, Cell type, age group and donor

DOCK2 VIM PDE4B ITGAX

3.57e-051984249bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCellParenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 SLC9A7 OR3A3 ITGAX

3.57e-05198424fa5c15a656d4132950092919600e270f1fd79abf
ToppCellNS-control-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DOCK2 VIM PDE4B ITGAX

3.57e-05198424846852943a8ff60f746fd49498240e25ca1c1b09
ToppCellBronchial_Biopsy-Immune|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

DOCK2 VIM PDE4B ITGAX

3.57e-051984241c30eebbe16a331039a9063b93774b5daf518b6e
ToppCellcontrol-Myeloid|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DOCK2 VIM PDE4B ITGAX

3.57e-051984245cfd9e600c417d7e7146a620a1871dde7163389b
ToppCell356C-Myeloid-Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells)

VIM PDE4B ELL2 ITGAX

3.57e-05198424ad5b9a92f3ad7f4220f173cee4dba0977bd803fe
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

VIM JARID2 ELL2 ITGAX

3.57e-051984243a1707318814dabdec48f91fa6bd223f5b879653
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JARID2 PDE4B ELL2 ITGAX

3.57e-05198424c288b29287a562460d8970264e1833801590da73
ToppCellIPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class

JARID2 RNASE1 ELL2 ITGAX

3.64e-051994243c2b362d5e824e1a04830e70352f8818de984174
ToppCellParenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PDE4B GLDN ITGAX

3.64e-051994247ee2805fd9143eba11bf6832267b62189683608b
ToppCellMacroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic

RNASE1 GLDN ELL2 EDIL3

3.72e-052004244dbac2f2587e87ca5a0622f50439bb5447e93c7f
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PDE4B GLDN ITGAX

3.72e-05200424a443e475e7a10c26a6173d1af961de6219e0e567
ToppCellControl_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type

VIM RNASE1 PDE4B EDIL3

3.72e-05200424041a34080120c9f613373c20dcc366292f558040
ToppCellControl_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

VIM RNASE1 PDE4B PML

3.72e-052004243b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCellBiopsy_Control_(H.)-Immune|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

DOCK2 VIM GLDN ITGAX

3.72e-05200424e1d50556ca116ef4b65ec29ab2ef7341f0d21451
ToppCellMacroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic

RNASE1 GLDN ELL2 EDIL3

3.72e-0520042426b989e30bbbaf30904ced03f6aae3dea25c732c
ToppCellParenchyma_COVID-19-Immune-TX-MoAM-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

DOCK2 PDE4B ELL2 ITGAX

3.72e-052004248fd88dfc6e08e0186fc0f061526ad98a3b00bc31
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

VIM RNASE1 PDE4B EDIL3

3.72e-05200424b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCellMacroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic

RNASE1 GLDN ELL2 EDIL3

3.72e-052004241314664c1721e9ecb1e2c3482a039044b0fe50a9
ToppCellControl_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

VIM RNASE1 PDE4B EDIL3

3.72e-05200424abf4ba5fcb54cdeada0da1a8b956a30aa47679e4
ToppCellMacroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic

RNASE1 GLDN ELL2 EDIL3

3.72e-052004248b229f095fc113aecfc94b64862a9e0fdcc363ce
ToppCellBronchus_Control_(B.)-Immune-TX-MoAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

VIM JARID2 PDE4B ITGAX

3.72e-05200424fe7f8b04067b6680b69c8523f0fa514ef97207e2
ToppCellMacroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic

RNASE1 GLDN ELL2 EDIL3

3.72e-05200424272909f4354f3ae22e2b2f8f35970e6b0e92cfe2
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PDE4B GLDN ITGAX

3.72e-05200424ed785a6d08ca2b350dc3307b587eadfb2886d1f9
ToppCellMacroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic

RNASE1 GLDN ELL2 EDIL3

3.72e-052004245f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca
ToppCellBronchus_Control_(B.)-Immune-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

DOCK2 VIM PDE4B ITGAX

3.72e-05200424ad0d38ffe5ca138b40823d15b239c2f9f3f0e93c
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

VIM RNASE1 ITGAX GYS1

3.72e-05200424851c57187db8bc91a393655bca5f13e787a723d4
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FSIP2 GLDN MUCL3

1.92e-041194238eefcf1ace62ad1c90fa5b62ec159c83ec527bf3
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK2 ITGAX GYS1

3.03e-04139423505bf5a483fc2ba69377db9850c3b26ab2f416d1
ToppCellICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type

FSIP2 HTR2B TRPC1

3.43e-04145423ee99b58462f955b96d036aa67e343db047d66f64
ToppCellFetal_29-31_weeks-Immune-dendritic_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DOCK2 SLC9A7 PDE4B

3.79e-0415042357f21ad380fd1350a2c25d75ad8c3b763ded53ec
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FSIP2 EDIL3 TRPC1

3.86e-0415142316fc903fc71e25717b9908416f0bcd29c0a65a61
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RNASE1 HYDIN SLC22A1

4.02e-04153423edf5d026e8e4c685b7c369d70894741bb2cd568e
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RNASE1 HYDIN SLC22A1

4.02e-041534233240d4d690335ba22317b1f3d33f9ea069e93838
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RNASE1 HYDIN SLC22A1

4.09e-04154423ec56b7fb88e39041416c384f371c767f3b4e92fa
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RNASE1 EDIL3 MUCL3

4.17e-04155423babcb9e548f04ace8157d506d27c5941c692c491
Diseaseanxiety disorder, stress-related disorder

PDE4B EDIL3

1.17e-0412402EFO_0006788, EFO_0010098
DiseaseGlioblastoma

MTOR DEUP1 PML

1.70e-0479403C0017636
Diseasetriglycerides to total lipids in chylomicrons and extremely large VLDL percentage

APOB SLC22A1

1.86e-0415402EFO_0022328
Diseaseresponse to statin, LDL cholesterol change measurement

APOB MYLIP

1.86e-0415402EFO_0007804, GO_0036273
DiseaseGiant Cell Glioblastoma

MTOR DEUP1 PML

2.04e-0484403C0334588
Diseaseintermediate density lipoprotein measurement

APOB SLC22A1 MYLIP

2.26e-0487403EFO_0008595
Diseasecholesterol to total lipids in chylomicrons and extremely large VLDL percentage

APOB SLC22A1

2.41e-0417402EFO_0022232
Diseasecoronary artery calcification

FSIP2 APOB ELL2 ATXN7L1 MYLIP

3.42e-04450405EFO_0004723
Diseasecholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage

APOB SLC22A1

3.70e-0421402EFO_0022246
Diseaseapolipoprotein A 1 measurement, apolipoprotein B measurement

APOB SLC22A1 MYLIP

4.15e-04107403EFO_0004614, EFO_0004615
DiseaseGlioblastoma Multiforme

MTOR DEUP1 PML

4.63e-04111403C1621958
Diseaselipoprotein A measurement

APOB ARID1B SLC22A1

4.75e-04112403EFO_0006925
Diseaselow density lipoprotein cholesterol measurement, lipid measurement

APOB SLC22A1 MYLIP

5.00e-04114403EFO_0004529, EFO_0004611
Diseasetotal cholesterol measurement, low density lipoprotein cholesterol measurement

APOB SLC22A1 MYLIP

5.00e-04114403EFO_0004574, EFO_0004611
Diseaseglycoprotein measurement

APOB HYDIN SLC22A1

5.67e-04119403EFO_0004555
Diseaselow density lipoprotein cholesterol measurement, phospholipid measurement

APOB SLC22A1 MYLIP

5.81e-04120403EFO_0004611, EFO_0004639
Diseaseacute kidney failure (implicated_via_orthology)

MTOR SLC22A1

6.16e-0427402DOID:3021 (implicated_via_orthology)
Diseasecholesteryl ester measurement, low density lipoprotein cholesterol measurement

APOB SLC22A1 MYLIP

6.69e-04126403EFO_0004611, EFO_0010351
Diseasefree cholesterol measurement, low density lipoprotein cholesterol measurement

APOB SLC22A1 MYLIP

8.53e-04137403EFO_0004611, EFO_0008591
DiseaseSchizophrenia

JARID2 DLGAP1 PDE4B RAPGEF6 MTOR PML

1.14e-03883406C0036341
DiseaseColonic Neoplasms

MCM2 MTOR SLC22A1

1.15e-03152403C0009375
Diseaseautism spectrum disorder (implicated_via_orthology)

ARID1B HTR2B TRPC1

1.15e-03152403DOID:0060041 (implicated_via_orthology)
DiseaseMalignant tumor of colon

MCM2 MTOR SLC22A1

1.31e-03159403C0007102
DiseasePulmonary Hypertension

EIF2AK4 HTR2B

1.35e-0340402C0020542
Diseasecholesterol in very small VLDL measurement

APOB SLC22A1

1.35e-0340402EFO_0022231
Diseasecervical cancer

JARID2 PDE4B

1.35e-0340402MONDO_0002974

Protein segments in the cluster

PeptideGeneStartEntry
MYQSPMRLRSSTIQS

HTR2B

441

P41595
ATNDSYQMTRERMTQ

ELL2

126

O00472
AYRTMMAQIFSQRIS

EIF2AK4

1026

Q9P2K8
MASAVTTFNTYTRMV

GSG1

246

Q2KHT4
SRNESYMRAMSTISQ

DLGAP1

436

O14490
RTSQSVLAMLAYNMR

GLDN

511

Q6ZMI3
VSQRQPYMSSSASMQ

ARID1B

1586

Q8NFD5
YMSMDFTNREQSRHT

DEUP1

441

Q05D60
RLTSSYIMTSAMLSN

ATXN7L1

551

Q9ULK2
SISSRNFATMMNFVR

ITGAX

161

P20702
SFIDTQKFSVMRSMR

MCM2

801

P49736
TEYSMTSSVMRRNEQ

LTV1

241

Q96GA3
MAFVTRQFMRSVSSS

HADH

1

Q16836
STMDSFTLIMQTYNR

EXTL2

61

Q9UBQ6
RFQRQASTMYTTMLS

FSIP2

4776

Q5CZC0
RVTMTRNTSISTAYM

IGHV1-8

86

P0DP01
YSTRMSQTVQRMLVA

OR3A2

141

P47893
YSTRMSQTVQRMLVA

OR3A3

141

P47888
FRISSDTFITYMMTL

PDE4B

381

Q07343
RCDTVTSAVMMQYSR

MYLIP

276

Q8WY64
AILTNQYMQRLSTMR

PABPC1L

376

Q4VXU2
ERLSQMTNTTMQTRY

IL9

71

P15248
MTNTTMQTRYPLIFS

IL9

76

P15248
IYFNSMSQMNRQTRR

DTX1

151

Q86Y01
TASSIFRTLNMDMFT

EDIL3

336

O43854
EATMTFKYNRQSMTL

APOB

1046

P04114
YQTQATRRILMMNTG

HYDIN

4541

Q4G0P3
MLRSYRQMSIISLAS

DOCK2

1636

Q92608
LMTSYSMRSTVVSRY

ITIH6

36

Q6UXX5
TMMKRAIFATQRQSF

GYS1

426

P13807
GSRRTVAIMYQMAFT

SLC22A1

231

O15245
SYMMRTRRTLTQNTQ

MUCL3

471

Q3MIW9
SLTTFYRTARNIMSM

JARID2

821

Q92833
SSQVYFMTLNRNCIM

MINK1

1316

Q8N4C8
RRTNYTRSLAVMSMV

MTOR

2316

P42345
MYASVFFLTAMSVTR

RXFP3

166

Q9NSD7
RNMAKYRNILSSQSM

RAPGEF6

991

Q8TEU7
AIRDTATYARQMMFS

SLC9A6

466

Q92581
QTYLARNMSERSAMA

PML

731

P29590
SPSSSSTYCNQMMRR

RNASE1

46

P07998
RYLTSMRQKMQSTDQ

TRPC1

741

P48995
MSTRSVSSSSYRRMF

VIM

1

P08670
TASYARQMMFTTTLL

SLC9A7

501

Q96T83